More people entered the labor force, and not all were able to find jobs right away. Bad weather may have been a factor
Consumers like curation—stories that narrow the choices down to the best two or three
With yet another tweak to the health-care law, the Obama administration is heading off a popular Republican attack
Music executives are tapping services such as Shazam and Spotify to help predict tomorrow’s next big hits
In the five years since the most recent bottom, the stock market has very nearly tripled
Arunachalam Muruganantham, aka "Menstrual Man," designed simple devices that allow rural Indian women to make their own sanitary pads
The company's dubbing of storms with Greek and Latin names began in 2012 to help 'personalize' extreme weather
European MBA programs compete with top-tier U.S. schools for the best students at home and abroad
Organizations offer special training for senior entrepreneurs
Founders: Jeff Stein, John Finn, and John Schmid
VC Investment over the last four quarters: $35.16 million
Founded in 2004, the 35-employee biopharmaceutical company is working to develop antibacterial drugs to treat infections caused by resistant bacteria. Besides the VC investment, Stein says Trius has raised $32 million in government grants and contracts. As far as his perspective on the impact of the recession on his company, which expects less than $1 million in revenues in 2008, Stein says it will make the fundraising environment more challenging and may impact the partner environment as well.
Key to startup success: "Recruit top-tier executives. Focus on advancing your most valuable asset and seek alternative financing for earlier-stage programs."